Last updated: August 17, 2026

nbscience

Title: Management of patients with tumors of the gastrointestinal tract

Start Date: 2024-05-17
End Date: 2024-05-18

 Conditions of participation for participants:

Registration Package   includes participation in scientific sessions, conference materialsvisit to the exhibitio

 

AGENDA

DAY 1

Therapy in Gastroesophageal Cancer

Metastatic Pancreatic Cancer

Should Neoadjuvant Therapy for Pancreatic Cancer Adenocarcinoma be the Standard for All Patients? No!

Using Biomarkers to Manage Therapy in Advanced Colorectal Cancer

The Future of Cooperative Clinical Research in Gastrointestinal Oncology

Systemic Therapy for Cholangiocarcinoma

Topography of Chronic Active Gastritis Among  Helicobacter Pylori Positive Patients

A Retrospective Single Study Analysis of Survival Outcomes in Metastatic Colorectal Cancer

DAy 2  

Efficacy of Endoscopic Submucosal Dissection for Early Gastric Neoplasms

HER2 Status in Gastric Adenocarcinoma

Temozolomide and Thalidomide for Neuroendocrine Tumors

Erlotinib and Radiation Therapy for Elderly Patients With Esophageal Cancer

Hyperbaric Oxygen Therapy

 

tickets ukraine

from 50 Euros ( one way) : http://wizzair.com/?language=EN

Questions

Contact NBScience’s

Education/Conference Department:

 

[email protected]

pharmacology

Scientific case review

Scientific Case Review

Would you like to understand whether current clinical programs, recent research developments, or emerging approaches may be relevant to your individual situation?

Share your question with our scientific research team and receive information focused on the areas of current research that may be relevant to your case.

  • Review of the information you provide
  • Relevant research and clinical program information
  • A clear response focused on your situation
What happens next? Send your question, receive a focused scientific review, and get a clear response about research and clinical programs relevant to your situation.
Your scientific review will be prepared by Dr. Helen Melnik, PhD , who has more than 25 years of experience in stem cell research and international clinical programs.

No obligation. Your question will be reviewed confidentially.

Educational and research information only. This service does not constitute medical advice, diagnosis, prescription, or a personalized treatment recommendation.

Categories: oncology conferences

NBScience

contract research organization

WhatsApp